Anthony H Nguyen

Array ( [id] => 3949389 [patent_doc_number] => 05998597 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-07 [patent_title] => 'Method for improved selectivity in photo-activation of molecular agents' [patent_app_type] => 1 [patent_app_number] => 8/989231 [patent_app_country] => US [patent_app_date] => 1997-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 23 [patent_no_of_words] => 16135 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/998/05998597.pdf [firstpage_image] =>[orig_patent_app_number] => 989231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4256839 [patent_doc_number] => 06204027 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-20 [patent_title] => 'Ribozymes having 2\'-O substituted nucleotides in the flanking sequences' [patent_app_type] => 1 [patent_app_number] => 8/987032 [patent_app_country] => US [patent_app_date] => 1997-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 4578 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/204/06204027.pdf [firstpage_image] =>[orig_patent_app_number] => 987032 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4298273 [patent_doc_number] => 06184372 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-06 [patent_title] => 'Antisense interleukin 10 and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/980975 [patent_app_country] => US [patent_app_date] => 1997-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 18173 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/184/06184372.pdf [firstpage_image] =>[orig_patent_app_number] => 980975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4163528 [patent_doc_number] => 06139833 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-31 [patent_title] => 'Targeted gene discovery' [patent_app_type] => 1 [patent_app_number] => 8/907598 [patent_app_country] => US [patent_app_date] => 1997-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 23982 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/139/06139833.pdf [firstpage_image] =>[orig_patent_app_number] => 907598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 790707 [patent_doc_number] => 06984729 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-01-10 [patent_title] => 'Oligonucleotides specific for hepatitis B virus' [patent_app_type] => utility [patent_app_number] => 08/901612 [patent_app_country] => US [patent_app_date] => 1997-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 12221 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/984/06984729.pdf [firstpage_image] =>[orig_patent_app_number] => 08901612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6890540 [patent_doc_number] => 20010007771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-07-12 [patent_title] => 'CATIONIC POLYMERS AND LIPIDS FOR THE DELIVERY OF NUCLEIC ACIDS' [patent_app_type] => new-utility [patent_app_number] => 08/865375 [patent_app_country] => US [patent_app_date] => 1997-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11143 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0007/20010007771.pdf [firstpage_image] =>[orig_patent_app_number] => 08865375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 623670 [patent_doc_number] => 07138378 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-11-21 [patent_title] => 'Genetic suppression and replacement' [patent_app_type] => utility [patent_app_number] => 09/155708 [patent_app_country] => US [patent_app_date] => 1997-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 13485 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/138/07138378.pdf [firstpage_image] =>[orig_patent_app_number] => 09155708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 359577 [patent_doc_number] => 07485456 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-02-03 [patent_title] => 'Modulators of TNF receptor associated factor (TRAF), their preparation and use' [patent_app_type] => utility [patent_app_number] => 09/155676 [patent_app_country] => US [patent_app_date] => 1997-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 10 [patent_no_of_words] => 24556 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/485/07485456.pdf [firstpage_image] =>[orig_patent_app_number] => 09155676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4092263 [patent_doc_number] => 06133437 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Modulation of IAPs for the treatment of proliferative diseases' [patent_app_type] => 1 [patent_app_number] => 8/800929 [patent_app_country] => US [patent_app_date] => 1997-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 37 [patent_no_of_words] => 27156 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/133/06133437.pdf [firstpage_image] =>[orig_patent_app_number] => 800929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4412210 [patent_doc_number] => 06229006 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-08 [patent_title] => 'Use of antisense oligodeoxynucleotides to produce truncated proteins' [patent_app_type] => 1 [patent_app_number] => 8/770473 [patent_app_country] => US [patent_app_date] => 1996-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 2153 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/229/06229006.pdf [firstpage_image] =>[orig_patent_app_number] => 770473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4192429 [patent_doc_number] => 06153742 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-28 [patent_title] => 'General process for the preparation of cyclic oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 8/731202 [patent_app_country] => US [patent_app_date] => 1996-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8573 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/153/06153742.pdf [firstpage_image] =>[orig_patent_app_number] => 731202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3981799 [patent_doc_number] => 05948901 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-07 [patent_title] => 'Antisense oligonucleotides for aromatase inhibition' [patent_app_type] => 1 [patent_app_number] => 8/605190 [patent_app_country] => US [patent_app_date] => 1996-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 2426 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/948/05948901.pdf [firstpage_image] =>[orig_patent_app_number] => 605190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1549401 [patent_doc_number] => 06346398 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-12 [patent_title] => 'Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor' [patent_app_type] => B1 [patent_app_number] => 08/584040 [patent_app_country] => US [patent_app_date] => 1996-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 24 [patent_no_of_words] => 47946 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/346/06346398.pdf [firstpage_image] =>[orig_patent_app_number] => 08584040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4139033 [patent_doc_number] => 06015892 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-18 [patent_title] => 'Oligonucleotide modulation of protein kinase C' [patent_app_type] => 1 [patent_app_number] => 8/578615 [patent_app_country] => US [patent_app_date] => 1996-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 17 [patent_no_of_words] => 16426 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/015/06015892.pdf [firstpage_image] =>[orig_patent_app_number] => 578615 [rel_patent_id] =>[rel_patent_doc_number] =>)